MA42135A - Méthodes et trousses pour traiter la dépression - Google Patents

Méthodes et trousses pour traiter la dépression

Info

Publication number
MA42135A
MA42135A MA042135A MA42135A MA42135A MA 42135 A MA42135 A MA 42135A MA 042135 A MA042135 A MA 042135A MA 42135 A MA42135 A MA 42135A MA 42135 A MA42135 A MA 42135A
Authority
MA
Morocco
Prior art keywords
kits
methods
treating depression
depression
treating
Prior art date
Application number
MA042135A
Other languages
English (en)
Inventor
Ivo Caers
Ella Daly
Wayne C Drevets
Jaskaran Singh
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA42135A publication Critical patent/MA42135A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emergency Medicine (AREA)
  • Steroid Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA042135A 2015-05-20 2016-05-20 Méthodes et trousses pour traiter la dépression MA42135A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562164026P 2015-05-20 2015-05-20

Publications (1)

Publication Number Publication Date
MA42135A true MA42135A (fr) 2018-03-28

Family

ID=57320901

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042135A MA42135A (fr) 2015-05-20 2016-05-20 Méthodes et trousses pour traiter la dépression

Country Status (20)

Country Link
US (1) US20160338977A1 (fr)
EP (1) EP3297618A4 (fr)
JP (1) JP2018515557A (fr)
KR (1) KR20180008634A (fr)
CN (1) CN107735081A (fr)
AU (3) AU2016263598A1 (fr)
CA (1) CA2986477A1 (fr)
CL (1) CL2017002904A1 (fr)
CO (1) CO2017011564A2 (fr)
DO (1) DOP2017000268A (fr)
EA (1) EA201792545A1 (fr)
EC (1) ECSP17077930A (fr)
GT (1) GT201700246A (fr)
HK (1) HK1252937A1 (fr)
IL (1) IL255463A (fr)
MA (1) MA42135A (fr)
MX (1) MX2017014797A (fr)
PE (1) PE20180260A1 (fr)
PH (1) PH12017502103A1 (fr)
WO (1) WO2016187491A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014240102A1 (en) 2013-03-15 2015-09-17 Janssen Pharmaceutica Nv Pharmaceutical composition of S-ketamine hydrochloride
CA2957926A1 (fr) 2014-08-13 2016-02-18 Janssen Pharmaceutica Nv Methode de traitement de la depression
AU2015318123A1 (en) 2014-09-15 2017-03-30 Janssen Pharmaceutica Nv Val66Met (SNP rs6265) genotype specific dosing regimens and methods for the treatment of depression
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN107847469A (zh) 2015-06-27 2018-03-27 美国神农制药责任有限公司 氯胺酮透皮递送系统
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
IL319020A (en) * 2017-12-22 2025-04-01 Janssen Pharmaceuticals Inc Esketamine for the treatment of depression
HUE058320T2 (hu) 2017-12-29 2022-07-28 Celon Pharma Sa Száraz por alakú ketamin készítmény pulmonáris adagolásra kezelésnek ellenálló depresszió esetén
EP3813807A1 (fr) * 2018-06-27 2021-05-05 Clexio Biosciences Ltd. Procédé de traitement d'un trouble dépressif majeur
ES3021221T3 (en) * 2018-09-28 2025-05-26 Novohale Therapeutics Llc Ketamine composition for use in a method of treatment of depression by pulmonary administration
WO2020070547A1 (fr) * 2018-10-05 2020-04-09 Clexio Biosciences Ltd. Régime posologique d'eskétamine pour le traitement d'un trouble dépressif majeur
WO2020070706A1 (fr) * 2018-10-05 2020-04-09 Clexio Biosciences Ltd. Régime posologique d'eskétamine pour le traitement d'un trouble dépressif majeur
KR20210074275A (ko) * 2018-10-05 2021-06-21 클렉시오 바이오사이언시스 리미티드 주요 우울 장애를 치료하기 위한 에스케타민의 복용 요법
US12364672B2 (en) 2018-10-11 2025-07-22 Clexio Biosciences Ltd. Esketamine for use in treating major depressive disorder
WO2020178653A1 (fr) * 2019-03-05 2020-09-10 Janssen Pharmaceuticals, Inc. Eskétamine pour le traitement de la dépression
EP4021432A4 (fr) * 2019-08-28 2023-08-16 Janssen Pharmaceuticals, Inc. Eskétamine pour le traitement de patients présentant un trouble dépressif majeur, notamment la suicidalité
TW202135787A (zh) 2019-12-12 2021-10-01 比利時商健生藥品公司 艾氯胺酮調配物及製備與儲存的方法
US12268658B2 (en) 2019-12-30 2025-04-08 Clexio Biosciences Ltd. Dosage regime with esketamine for treating major depressive disorder
US12478592B2 (en) 2019-12-30 2025-11-25 Clexio Biosciences Ltd. Dosage regime with esketamine for treating neuropsychiatric or neurological conditions
MX2022014948A (es) * 2020-05-28 2023-03-13 Janssen Pharmaceutica Nv Métodos para tratar la depresión.
GB202019952D0 (en) * 2020-12-17 2021-02-03 Neurocentrx Pharma Ltd Novel compositions
WO2022235576A1 (fr) * 2021-05-03 2022-11-10 Wang Michael Z Méthodes et compositions pour le traitement de la dépression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007229866A1 (en) * 2006-03-22 2007-10-04 Mount Sinai School Of Medicine Intranasal administration of ketamine to treat depression
US20110038807A1 (en) * 2009-08-14 2011-02-17 Demitri Papolos Compositions and methods for treating bipolar disorder
WO2013003669A2 (fr) * 2011-06-30 2013-01-03 University Of South Florida Compositions, méthodes d'utilisation et méthodes de traitement
WO2013138322A1 (fr) * 2012-03-12 2013-09-19 Janssen Pharmaceutica Nv Eskétamine dans le traitement de la dépression réfractaire ou résistante aux traitements
JP2015512418A (ja) * 2012-03-30 2015-04-27 ザ ジェネラル ホスピタル コーポレイション うつ病の治療におけるスコポラミンおよびケタミンを含む組成物
MX370506B (es) * 2013-04-12 2019-12-16 Icahn School Med Mount Sinai Método para tratar trastorno de estrés post-traumático.
AU2015318123A1 (en) * 2014-09-15 2017-03-30 Janssen Pharmaceutica Nv Val66Met (SNP rs6265) genotype specific dosing regimens and methods for the treatment of depression

Also Published As

Publication number Publication date
EA201792545A1 (ru) 2018-05-31
MX2017014797A (es) 2018-02-15
AU2016263598A8 (en) 2017-11-30
AU2023237026A1 (en) 2023-10-12
CO2017011564A2 (es) 2018-04-19
DOP2017000268A (es) 2018-04-15
CL2017002904A1 (es) 2018-04-20
GT201700246A (es) 2019-07-29
PE20180260A1 (es) 2018-02-05
CN107735081A (zh) 2018-02-23
WO2016187491A1 (fr) 2016-11-24
AU2016263598A1 (en) 2017-11-23
KR20180008634A (ko) 2018-01-24
US20160338977A1 (en) 2016-11-24
ECSP17077930A (es) 2018-02-28
PH12017502103A1 (en) 2018-05-07
JP2018515557A (ja) 2018-06-14
AU2021215155A1 (en) 2021-09-02
HK1252937A1 (zh) 2019-06-06
IL255463A (en) 2018-01-31
EP3297618A1 (fr) 2018-03-28
CA2986477A1 (fr) 2016-11-24
EP3297618A4 (fr) 2019-01-23

Similar Documents

Publication Publication Date Title
EP3297618A4 (fr) Méthodes et trousses pour traiter la dépression
IL282570B (en) Methods and devices for treating pulmonary edema
EP3328377A4 (fr) Compositions et méthodes pour thérapies immuno-oncologiques
IL269371A (en) Treatment methods
IL257252A (en) Methods of treating fgf21-associated disorders
IL299926A (en) Neoantigens and methods of their use
PL3301990T3 (pl) Sposób i przyrząd do ustanawiania powiązania
IL251215B (en) Cannabinoid composition and method for treating pain
DE102014017707A8 (de) Beschichtungsverfahren und entsprechende Beschichtungsanlage
EP3519833A4 (fr) Méthodes de pronostic et de traitement
PL3117909T3 (pl) Urządzenie aplikujące i sposób aplikacji
BR112016027102A2 (pt) método e aparelho
IL251759B (en) Compositions and methods for treating insomnia
PT3265087T (pt) Método de tratamento com tradipitant
MA50062A (fr) Méthodes permettant de traiter la dystrophie musculaire
PL3386655T3 (pl) Sposób przetwarzania odpadów
EP3258925A4 (fr) Méthodes et compositions pour réduire la vidange gastrique
EP3630732A4 (fr) Méthode et molécules
PL3393468T3 (pl) Metody leczenia niedoboru odporności
IL272092A (en) Methods of treating behavior alterations
EP4057700C0 (fr) Procédé et appareil d'accès multi-utilisateur
IL254783A0 (en) Anthelmintic combinations and methods of use thereof
EP3307742A4 (fr) Méthodes pour traiter ou prévenir une protéopathie
FI20145633A7 (fi) Menetelmä biolietteen käsittelemiseksi
EP3454852A4 (fr) Inhibiteurs de phosphotidylinositol 3-kinases